Demonstrates enhanced imaging of H2O2 in liver injury, suggesting effective therapeutic implications.
We developed an HSC-targeted nanoplatform integrating a mitochondrial H₂O₂/viscosity cascade-responsive fluorescent probe with melatonin, enabling real-time imaging of H₂O₂/viscosity dynamics in HSC during hepatic ischemia-reperfusion injury and simultaneous ROS scavenging to mitigate liver injury, offering a cell-specific theranostic tool.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: